Hypersensitivity to the active substance or to any of the excipients listed in Description.
Concomitant use of moderate or strong CYP1A2 inhibitors (see Interactions).
Known or suspected pregnancy (see Use in Pregnancy & Lactation).
Other Services
Country
Account